Liver Dose Deposition (mGy)

Slides:



Advertisements
Similar presentations
ARDENT MEETING Andrej Sipaj October 14 th, ABOUT ME Born and raised in Slovakia Studied: BEng in Mechanical Enginnering at UOIT, Canada MASc in.
Advertisements

GEANT4 simulation of an ocular proton beam & benchmark against MC codes D. R. Shipley, H. Palmans, C. Baker, A. Kacperek Monte Carlo 2005 Topical Meeting.
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Nuclear Physics. Outcomes What are some of the other uses for radiation? What are the effects of radiation on humans? How can we measure exposure to radiation?
From nebulae segmentation in astronomical imaging to tumor delineation in 18F-FDG PET imaging: how can one serve the other? M. Hatt 1, C. Collet 2, F.
Multi-tracer analysis for patient’s following using multi-observation statistical image fusion : a feasibility study S. David 1, M. Hatt 1, P. Fernandez.
Transforming Static CT in Gated PET/CT Studies to Multiple Respiratory Phases M Dawood, F Büther, N Lang, X Jiang, KP Schäfers Department of Nuclear Medicine,
Kirov A S, MSKCC Overview of Geant4 Use and Issues in Imaging: Emission Tomography (PET and SPECT) Assen S. Kirov Department of Medical Physics Memorial.
MONTE CARLO RADIATION DOSE SIMULATIONS AND DOSIMETRY COMPARISON OF THE MODEL 6711 AND I BRACHYTHERAPY SOURCES Mark J. Rivard Department of Radiation.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Liver Cancer Management with Y90 Glass Microspheres – TheraSphere Experience and Challenges in HCC Thomas Lauenstein, MD Department of Diagnostic and.
Patient Dosimetry in Radiology, Management Center Europe, June
Targeted Gold Nanoparticles as Vascular Disrupting Agents during Radiation Therapy RI Berbeco 1, H Korideck 1, S Kunjachan 1, R Kumar 2, S Sridhar 2, A.
Shannon M MacDonald 1, Salahuddin Ahmad 2, Stefanos Kachris 3, Betty J Vogds 2, Melissa DeRouen 3, Alicia E Gitttleman 3, Keith DeWyngaert 3, Maria T Vlachaki.
DIGITAL HIGH-RESOLUTION HEART PHANTOMS Abstract Background:X-ray based imaging modalities employ ionizing radiation with the potential for causing harmful.
H. Koivunoro1, E. Hippelänen1, I. Auterinen2, L. Kankaanranta3, M
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Dr Richard J Owen – Interventional Radiology
M.G. Pia et al. Brachytherapy at IST Results from an atypical Comparison Project Stefano Agostinelli 1,2, Franca Foppiano 1, Stefania Garelli 1, Matteo.
G. Bartesaghi, 11° ICATPP, Como, 5-9 October 2009 MONTE CARLO SIMULATIONS ON NEUTRON TRANSPORT AND ABSORBED DOSE IN TISSUE-EQUIVALENT PHANTOMS EXPOSED.
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
1 1 contribution in NA4 (Medical applications), EGEE2 Scientific Contributors: F. Bellet H. Benoit-Cattin, deputy P. Clarysse L. Guigues C. Lartizien I.
Hodgkin’s Lymphoma in Young Female Patients Can be Safely Treated with Radiation: A New Technique That Avoids The Breasts And Decrease The Heart Dose.
A Continuity Equation Based Optical Flow Method for Cardiac Motion Correction in 3D PET Data M Dawood, C Brune, X Jiang, F Büther, M Burger, O Schober,
Color correction of pathological images *Tokiya Abe,Pinky A. Bautista, Yukako Yagi, John Gilbertson **Yuri Murakami, Masahiro Yamaguchi, Nagaaki Ohyama.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Introduction In positron emission tomography (PET), each line of response (LOR) has a different sensitivity due to the scanner's geometry and detector.
Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
Introduction to NM Omima Adam NMT 231. What is nuclear medicine NM Is the branch of medicine that uses radiation and nuclear properties of radionuclide's.
Population of 4D Computational Phantoms for CT Imaging Research and Dosimetry W. Paul Segars, PhD Carl E. Ravin Advanced Imaging Labs Duke University.
4D XCAT Phantom for Multimodality Imaging Research W. Paul Segars, PhD Carl E. Ravin Advanced Imaging Labs Duke University.
INFSO-RI Enabling Grids for E-sciencE Grid based telemedicine application for GATE Monte Carlo dosimetric studies using HOPE (Hospital Platform.
Monday Case of the Day A) The treatment was successful: The bremsstrahlung SPECT (Fig 2) indicates that 90 Y was deposited in the tumor. B) The treatment.
Positron Emission Tomography (PET) scans allow for functional imaging of the body’s metabolism, making it an effective tool for locating cancerous tumors.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology The high matrix acquisition technique for imaging of atherosclerotic.
JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV.
The Optimization of Reconstruction Method Reducing Partial Volume Effect in PET/CT 3D Image Acquisition Department of Nuclear Medicine, Samsung Medical.
Radiobiological concepts for treatment planning of schemes that combines external beam radiotherapy and systemic targeted radiotherapy (CIERT) Carlos Calderón.
Methods & Materials (continued)
RHD-DoPET CNAO test beam result (may 2014)
CORRELATION BETWEEN AREAS OF HIGH FDG UPTAKE ON PRE-TREATMENT PET/CT AND PREFERENTIAL SITES OF LOCAL RELAPSE AFTER CHEMO-RADIOTHERAPY FOR HEAD AND NECK.
Improved dose determination for Molecular Radiotherapy
"Approaches on the role of medical physicists in implementing the hybrid technologies in Nuclear Medicine". Papel de la FM en la implementación de los.
Proton beam range verification using proton activated fiducials and off-site PET AAPM Best in Physics, Indianapolis, August 7, 2013 Cho J1, Ibbott G1,
AUBERT Bernard*, GUILABERT Nadine°, LAMON Annick* and RICARD Marcel*
Proton range verification with PET: 68Zn, Cu and polycarbonate activation SNMMI Young Investigator Symposium, Vancouver, June 9, 2013 Cho J1, Ibbott.
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Very High Energy Electron for Radiotherapy Studies
Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer - DOI: / Fig. 1. Embolisation of the right.
Decay induced de-chelation of positron-emitting electron-capture daughters and its use in preclinical PET. G.W. Severin1, L.K. Kristensen2, J. Fonslet1,
Ant colony segmentation approach for volume delineation in PET.
Summary of the Compton-PET project
Tianshuai Liu1, Junyan Rong1, Peng Gao1, Hongbing Lu1
CNRS applications in medical imaging
4D eXtended CArdiac-Torso (XCAT) Phantoms
TITLE Authors Institution RESULTS INTRODUCTION CONCLUSION AIMS METHODS
PET-utilized proton range verification using 13N signals
OPTICAL MONITORING OF PHOTOSENSITIZER DIFFUSION INTO TISSUE
Feasibility of using O-18 for PET proton range verification
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Towards clickable radio-immunoconjugates
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
A subgroup analysis of a large multicenter study
Example of pretreatment (A and B) and 8-week posttreatment (C and D) PET CT images. Example of pretreatment (A and B) and 8-week posttreatment (C and D)
Chapter 17 Intensity-Modulated Radiation Therapy
Geant4 at IST Applications in Brachytherapy
Improving Image Accuracy of ROI in CT Using Prior Image
Correlation of changes in NAFCIST and PERCIST with cumulative activity with radium RaCl2 dose was negatively correlated with changes in NAFCIST.
Presentation transcript:

Liver Dose Deposition (mGy) Optimization of Image-based Dosimetry in Y90 Radioembolization: a Monte Carlo approach using the GATE simulation toolkit K. Mountris1, A. Autret2, P. Papadimitroulas1, G. Loudos3, D. Visvikis2, G. Nikiforidis1 1 Department of Medical Physics, School of Medicine, University of Patras, Rion, GR 265 04, 2 LaTIM, UMR 1101 INSERM, CHRU Brest, Brest, France 3 Department of Biomedical Engineering, Technological Educational institute of Athens, Ag. Spyridonos Street, Egaleo GR 122 10, Athens, Greece Introduction: Y90 Radioembolization is a selective internal radiation therapy based on the heterogeneous distribution of Y90 microspheres in the target area through the hepatic artery, exploiting the unique blood flow of the human liver. Purpose: The improvement of the pretreatment image-based (IB) dosimetry using as imaging surrogate macroaggregated albumin (MAA) labeled with Ga68 or Cu64 instead of Tc99m was investigated according to the correlation with the follow up image-based dosimetric results of Y90 microspheres PET acquisition , using Monte Carlo (MC) simulations. Methods: Results: Divergence (%) Tc99m-MAA Ga68-MAA Cu64-MAA IB tumor dose +1.58% -2.61% -0.36% IB liver dose +12.77% +4.26% +3.29% XCAT phantom generation with tumor of 0.178 kg MC simulations with GATE open source toolkit Y90 IB tumor dose: 147.28 Gy Y90 IB liver dose: 62.94 Gy 52.31 mGy liver dose deposition from 200 MBq Tc99m-MAA Liver Dose Deposition (mGy) Tc99m-MAA Ga68-MAA Cu64-MAA 52.31 33.35 66.01 OPL-EM / ML-EM reconstruction Y90 kernel convolution MC estimation of imaging surrogates’ dose deposition in liver 36.2 % decrease in dose for 100 MBq of Ga68-MAA 26.2 % increase in dose for 100 MBq of Cu64-MAA Conclusions: Ability to simulate PET-based follow up dosimetry exploiting the tiny branch of positron emission of Y90. Improvement in correlation with the pre-treatment planning using PET imaging surrogates. Ga68-MAA showed dosimetric improvement and decrease in dose deposition supports further research. The radiochemical stability of Cu64-MAA has to be investigated due to it’s appealing dosimetric results. References: Konstantinos Mountris et al. “Liver Radioembolization with microspheres Y90: Method Investigation and dosimetry improvement using Monte Carlo Simulations”, Master Thesis University of Patras, Greece.